Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation (Q45835): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Condição pediátrica caracterizada por nível de bilirrubina persistentemente aumentado acima de 85 umol/L (5 mg/dL) que se manifesta como amarelamento dos olhos, pele e outros tecidos de um recém-nascido devido a qualquer substância química que impede ou diminui a produção de leite materno pela mãe. | |||
| description / en | description / en | ||
A paediatric condition characterised by persistently increased level of bilirubin above 85 umol/l (5 mg/dL) manifesting as yellowing of the eyes, skin, and other tissues of a newborn due to any chemical substance that prevents or decreases the production of breast milk by the mother. | |||
Revision as of 14:04, 13 August 2026
A paediatric condition characterised by persistently increased level of bilirubin above 85 umol/l (5 mg/dL) manifesting as yellowing of the eyes, skin, and other tissues of a newborn due to any chemical substance that prevents or decreases the production of breast milk by the mother.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | KA87.2 |
||
| English | Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation |
A paediatric condition characterised by persistently increased level of bilirubin above 85 umol/l (5 mg/dL) manifesting as yellowing of the eyes, skin, and other tissues of a newborn due to any chemical substance that prevents or decreases the production of breast milk by the mother. |
